Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms

Staats, 2004, Incidence of constipation associated with long-acting opioid therapy: a comparative study, South Med J, 97, 129, 10.1097/01.SMJ.0000109215.54052.D8 Pappagallo, 2001, Incidence, prevalence and management of opioid bowel dysfunction, Am J Surg, 182, 11S, 10.1016/S0002-9610(01)00782-6 Schug, 2003, Opioid and non-opioid analgesics, Best Pract Res Clin Anaesthesiol, 17, 91, 10.1053/bean.2003.0267 Thorpe, 2001, Management of opioid induced constipation, Curr Pain Headache Rep, 5, 237, 10.1007/s11916-001-0037-7 Gutstein, 2001, Opioid analgesics De Luca, 1996, Insights into opioid action in the intestinal tract, Pharmacol Ther, 69, 103, 10.1016/0163-7258(95)02053-5 Thomas, 2008, Methylnaltrexone for opioid-induced constipation in advanced illness, N Engl J Med, 358, 2332, 10.1056/NEJMoa0707377 RELISTOR (methylnaltrexone bromide) [prescribing information]. Progenics® Pharmaceuticals, Inc, Tarrytown, NY, USA. Available from: www.relistor.com and www.wyeth.com/hcp/relistor/prescribing-information. [Accessed January 22, 2010.] Foss, 2001, A review of the potential role of methylnaltrexone in opioid bowel dysfunction, Am J Surg, 281, 19S, 10.1016/S0002-9610(01)00783-8 Brown, 1985, The use of quaternary narcotic antagonists in opiate research, Neuropharmacology, 24, 181, 10.1016/0028-3908(85)90072-3 Ho, 2003, Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes, J Pharmacol Exp Ther, 307, 1158, 10.1124/jpet.103.056697 Kurz, 2003, Opioid-induced bowel dysfunction: pathophysiology and potential new therapies, Drugs, 63, 649, 10.2165/00003495-200363070-00003 Shaiova, 2007, A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation, Palliat Support Care, 5, 161, 10.1017/S147895150707023X Blonsky, 2009, Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic non-malignant pain, J Pain, 10, S52, 10.1016/j.jpain.2009.01.277 Lewis, 1997, Stool form as a useful guide to intestinal transit time, Scand J Gastroenterol, 32, 920, 10.3109/00365529709011203 Farrar, 2001, Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale, Pain, 94, 149, 10.1016/S0304-3959(01)00349-9 Frank, 1999, Psychometric validation of a constipation symptom assessment questionnaire, Scand J Gastroenterol, 34, 870, 10.1080/003655299750025327 Slappendel, 2006, Validation of the PAC-SYM questionnaire for opioid induced constipation in patients with chronic low back pain, Eur J Pain, 10, 209, 10.1016/j.ejpain.2005.03.008 Portenoy, 1996, Opioid therapy for chronic nonmalignant pain: a review of the critical issues, J Pain Symptom Manage, 11, 203, 10.1016/0885-3924(95)00187-5 Bell, 2008, The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European survey (PROBE 1), Pain Med, 10, 35, 10.1111/j.1526-4637.2008.00495.x Culpepper-Morgan, 1992, Treatment of opioid-induced constipation with oral naloxone: a pilot study, Clin Pharmacol Ther, 52, 90, 10.1038/clpt.1992.106 Portenoy, 2008, Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study, J Pain Symptom Manage, 35, 458, 10.1016/j.jpainsymman.2007.12.005 Lembo, 2003, Chronic constipation, N Engl J Med, 349, 1360, 10.1056/NEJMra020995 Camilleri, 2008, A placebo-controlled trial of prucalopride for severe chronic constipation, N Engl J Med, 358, 2344, 10.1056/NEJMoa0800670 McShane, 1985, Constipation: consensual and empirical validation, Nurs Clin North Am, 20, 801, 10.1016/S0029-6465(22)01923-5 De Schepper, 2004, Opioids and the gut: pharmacology and current clinical experience, Neurogastroenterol Motil, 16, 383, 10.1111/j.1365-2982.2004.00513.x McMillan, 2004, Assessing and managing opiate-induced constipation in adults with cancer, Cancer Control, 11, 3S, 10.1177/10732748040110S302 Yuan, 2000, Methylnaltrexone for reversal of constipation due to chronic methadone use, JAMA, 283, 367, 10.1001/jama.283.3.367 Di Palma, 2007, A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation, Am J Gastroenterol, 102, 1964, 10.1111/j.1572-0241.2007.01365.x Becker, 2007, Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review, J Pain Symptom Manage, 34, 547, 10.1016/j.jpainsymman.2006.12.018 Chamberlain